Skip to main content
. 2022 Apr;23(4):1415–1423. doi: 10.31557/APJCP.2022.23.4.1415

Table 3.

Number of Cases for EOC Patients According to Cancer Stage

Variable Stage p-valuea
Localized Regional Distant
n (%) n (%) n (%)
Age at diagnosis (years) <0.001*
<40 37 (69.8) 9 (17.0) 7 (13.2)
40–49 14 (32.6) 11 (25.6) 18 (41.9)
50–59 14 (26.4) 24 (45.3) 15 (28.3)
60–69 7 (29.2) 2 (8.3) 15 (62.5)
≥70 2 (11.8) 6 (35.3) 9 (52.9)
District 0.350
Brunei Muara 46 (37.1) 33 (26.6) 45(36.3)
Tutong 12 (42.9) 9 (32.1) 7 (25.0)
Belait 14 (53.8) 5 (19.2) 7 (26.9)
Temburong 0 (0.0) 2 (50.0) 2 (50.0)
Ethnicity 0.443
Malay 60 (37.3) 44 (27.3) 57 (35.4)
Chinese 10 (50.0) 4 (20.0) 6 (30.0)
Others 4 (44.4) 4 (44.4) 1 (11.1)
Histology <0.001*
Serous carcinoma 11 (21.6) 15 (29.4) 25 (49.0)
Mucinous carcinoma 42 (68.9) 10 (16.4) 9 (14.8)
Endometrioid carcinoma 8 (38.1) 9 (42.9) 4 (19.0)
Clear cell carcinoma 6 (54.5) 3 (27.3) 2 (18.2)
Undifferentiated or other-epithelial 7 (15.2) 15 (32.6) 24 (52.2)

aFisher’s Exact test (comparing cancer stages); *statistically significant (p<0.05)